Tag: Life Sciences
Biden proposes ARPA-H, a health research agency to ‘end cancer’ modeled after DARPA
In a joint address to Congress last night, President Biden updated the nation on vaccination efforts and outlined his administration’s ambitious goals. Biden’s first 100 days have been characterized by sweeping legislative packages that could lift millions of Americans out of poverty and slow the clock on the climate crisis,…
Read More
Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too
Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has already established the largest database in the world for single cell immunity characteristics, and it has already used its machine…
Read More
LabCorp COVID-19 test kit has just been approved for sale over-the-counter
LabCorp has now become the first company to receive approval to sell its COVID-19 test kit over-the-counter without a prescription, according to a statement from the company. One of the largest diagnostics testing companies in the U.S., LabCorp could be a significant competitor to companies like EverlyWell, which received approvals…
Read More
NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test. The test’s approval is another step forward for precision therapies that rely on…
Read More
LabCorp’s at-home COVID-19 test kit is the first to be authorized by the FDA
LabCorp’s at-home COVID-19 test, which is called ‘Pixel,’ has received the first Emergency Use Authorization (EUA) for such a test missed by the U.S. Food and Drug Administration (FDA). The test is an at-home collection kit, which provides sample collection materials including a nasal swab to the user, who then…
Read More
Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test
SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. The study, published in Nature, shows performance on par with existing PCR-based molecular tests, the one ones currently authorized for use by…
Read More